The Guardian | Scientists warn that new drugs will require earlier diagnosis of Alzheimer's The Guardian “On top of that, we still do not know how much the pharmaceuticals companies are going to charge for their anti-dementia drugs once we have learned how to pinpoint those who should receive them,” added Karran. The news about solanezumab comes as ... |